ENTITY

Intercept Pharmaceuticals (ICPT US)

27
Analysis
Health CareUnited States
Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
more
Company Presentation14 Sep 2023 03:10
Company Presentation02 Aug 2023 20:30
Company Presentation27 Apr 2023 20:00
Company Presentation02 Mar 2023 21:30
Company Presentation13 Jan 2023 04:00
x